Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5866 posts found.

vr

New technology allows scientists to study the inside of cells using VR

October 20, 2020 Manufacturing and Production, Research and Development VR, Virtual reality, pharma

New virtual reality software allows researchers to “walk” inside cells and analyse them up close in order to better understand …
News
shutterstock_159488225

New treatment could extend survival in amyotrophic lateral sclerosis patients

October 20, 2020 Manufacturing and Production, Research and Development als, pharma

Research into an experimental drug combination shows that it could potentially extend the lives for sufferers of amyotrophic lateral sclerosis …
News
astrazeneca-sign

FDA grants priority review to AstraZeneca’s Tagrisso as an adjuvant for early-stage EGFR-mutated non-small cell lung cancer

October 20, 2020 Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Tagrisso

The FDA has revealed its decision to grant Priority Review to AstraZeneca’s Tagrisso (osimertinib) as an adjuvant treatment of patients …
News
shutterstock_3

EMA’s CHMP recommends conditional approval for Kite Pharma’s CAR T therapy for mantle cell lymphoma

October 20, 2020 Manufacturing and Production, Sales and Marketing CAR T, CAR-T, CHMP, EMA, kite pharma, lymphoma

Kite Pharma’s anti-CD19 chimeric antigen receptor (CAR) T cell therapy known as KTE-X19 has received positive recommendation from the EMA’s …
News
eu_member_flags

European Commission stands by €1bn remdesivir supply deal despite disappointing COVID-19 benefit

October 19, 2020 Manufacturing and Production, Sales and Marketing COVID-19, Europe, Gilead, remdesivir

As Europe continues to face down a rising second wave of COVID-19, the European Commission quickly moved to secure a …
News
800px-healthcare_workers_wearing_ppe_03_2

Man in US contracts COVID-19 for the second time with worse symptoms

October 13, 2020 Manufacturing and Production COVID, coronavirus

An American man has caught coronavirus for the second time, with the second infection being far more dangerous than the …
News

J&J halts COVID-19 vaccine study following unidentified participant illness

October 13, 2020 Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma

Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …
News
800px-who_flag

Head of WHO says herd immunity strategies for COVID-19 are ‘unethical’

October 13, 2020 Manufacturing and Production

Tedros Adhanom Ghebreyesus, Director of the World Health Organization, has warned against pursuing a strategy of herd immunity to fight …
News
bavencio

Bavencio/axitinib combo approved for NHS Scotland in advanced renal cell carcinoma

October 13, 2020 Manufacturing and Production, Sales and Marketing Merck, NHS, Pfizer, SMC

The Scottish Medicines Consortium (SMC) has given the go-ahead to Merck KGaA and Pfizer’s combination of their PD-L1 inhibitor immunotherapy …
News
800px-covid-19_-_covent_garden_london_uk_during_lockdown

UK Government ignored SAGE advice to impose full lockdown last month

October 13, 2020 Manufacturing and Production COVID, UK, UK Coronavirus, coronavirus

UK Government ministers ignored warnings three weeks ago that the country should go into a temporary full lockdown to reduce …
News

Dr Kevin Eggan named as Group Vice President, Head of Research and Early Development at BioMarin

October 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Eggan, appointments

BioMarin Pharmaceutical has welcomed Dr Kevin Eggan as its new Group Vice President, Head of Research and Early Development. He …
Appointment
david_nicholson

Allergan R&D Chief named as Chairman of Exscientia’s Board of Directors

October 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Exscientia, appointment

Artificial intelligence-driven drug discovery firm Exscientia has named industry veteran Dr David Nicholson, current Executive Vice President and Chief R&D …
Appointment
800px-eli_lilly_corporate_center_indianapolis_indiana_usa

Eli Lilly’s antibody COVID-19 therapy reduces virus levels and hospitalisations

October 8, 2020 Manufacturing and Production Eli Lilly, FDA

Eli Lilly is seeking Emergency Use Authorization from the FDA after releasing interim data based on early trial results.
News
president_of_the_united_states_donald_j

Regeneron applies for FDA Emergency Use Authorization for COVID-19 antibody treatment given to Trump

October 8, 2020 Manufacturing and Production COVID, Trump, coronavirus

Regeneron has announced that it has applied for an Emergency Use Authorization from the FDA for its experimental antibody therapy …
News
shutterstock_2

Gilead to meet rising remdesivir demand in Europe with new supply deal

October 8, 2020 Manufacturing and Production COVID-19, Europe, Gilead

The European Commission (EC) has signed a new joint procurement agreement (JPA) with pharma firm Gilead to improve access to …
News
The Gateway to Local Adoption Series

Latest content

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026